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Two peptides were synthesized, corresponding to the sequences (- 19 to - 7) and (-26 to - 17) of the pro- 
renin prosegment. Monoclonal antibodies were raised to these sequences and used to characterize human 
plasma inactive renin. Only anti (- 19 to - 7) reacted with inactive renin, as measured by direct assay or 
affinity chromatography. The data were used to evaluate two possible inactive renin stuctures: (i) plasma 
inactive renin is a truncated prorenin lacking the prosegment N-terminal portion; (ii) its spatial conforma- 
tion masks the N-terminal extremity, preventing interaction of this region with specific antibodies. 
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1. INTRODUCTION 
Renin (EC 3.4.23.15) is a key enzyme in the 
regulation of blood pressure and electrolyte 
metabolism. This enzyme is synthesized in the jux- 
taglomerular cells of the kidney as an inactive 
biosynthetic precursor: preprorenin, prorenin and 
renin are then secreted [l-3]. Two forms of human * 
renin exist in plasma, kidney and chorionic cells: 
an inactive form and an active form [ 1,2]. Inactive 
renin can be activated by limited proteolysis or 
acidification [ 1,2]. 
The amino acid sequence of the plasma inactive 
renin is unknown. But, much information has been 
provided by the primary structure of human 
preprorenin determined by cloning and sequencing 
of the cDNA and gene [4,5]. Recently, Hirose et al. 
[6] demonstrated that the precursor of human 
renin contains a 23 residue signal peptide and a 
Abbreviations: GU, Goldblatt Unit; RIMA, radioim- 
munometric assay; BRA, plasma renin activity; EIMA, 
enzymoimmunometric assay 
prosegment of 43 residues (fig. 1). An immunologic 
similarity between inactive renin and prorenin has 
been determined by Bouhnik et al. [7] and Kim et 
al. [S] using polyclonal antibodies directed against 
synthetic peptides having the sequence of the pro- 
segment of the renin. 
With a view to determine the structure of inac- 
tive human plasma renin and the length of the pro- 
segment, two overlapping peptides have been 
synthesized. In this approach the analysis of the 
chorionic or plasma inactive renin has been ex- 
ecuted by direct assay of this enzyme using region 
specific monoclonal antibodies raised against the 
two synthetic peptides. 
2. MATERIALS AND METHODS 
2.1. Human renin sources 
2.1.1. Chorionic inactive renin 
Inactive renin released into the medium of 
cultured human chorionic cells was used [9]. The 
concentration of active renin was 6 mGU and of 
inactive renin was 40 mGU/ml medium. 
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2.12. Plasma renin 
Human blood was collected at 4°C on heparin, 
centrifuged and the plasma stored at -2O’C. A 
number of plasma samples were pooled before use. 
2.2. Renin mono~~onul antibodies 
The two human antirenin monoclonal an- 
tibodies used (3E8 and 4G1) have been described 
[lo]. Antibody 3E8 recognizes prorenin and renin 
while 4Gl is specific for active renin. 
2.3. Freparat~o~ of F&b) ‘2 antibodies 
Samples of antibody 3E8 were dialysed against 
sodium formate buffer, pH 2.8, followed by a 
dialysis against sodium acetate buffer, pH 4.2 [I 11. 
The F(ab)‘2 fragments were then prepared by 
digestion with pepsin (1 mg/ml) for 5 h at 37°C. 
2.4. r~~u~ogen preparation 
Hirose et al. [6] have determined that the proseg- 
ment contains 43 residues by sequential Edman 
degradation of “S Met-radiolabelled human pro- 
renin. These 43 residues are numbered negatively 
from the activation site (- 43 to - 1) in the present 
study. 
The peptide (- 26 to - 17) was synthesized by 
the same method used to synthesize peptide (- 19 
to - 7) (61. An extra tyrosyl residue was added at 
the N-terminus to permit iodination. The two pep- 
tides are called: (- 26 to - 17) and (- 19 to - 7). 
Pure peptides as established by amino acid analysis 
were obtained by preparative HPLC. Each peptide 
was coupled to bovine serum albumin using 
glutaraldehyde [121. The coupling efficiency was 
65% (2 mol peptide/mol BSA) as evaluated after 
dialysis by adding 12’ I (peptide) to the reaction 
mixture. 
2.5. Immunization, cellular fusion, screening and 
cloning 
(i) High responder Biozzi mice were immunized 
by subcutan~us injection with a mixture contain- 
ing 1Opg of each peptide [14]. After three injec- 
tions, selected mice received 5 ag (- 26 to - 17) 
and 5 pg (- 19 to - 7) intravenously. 
(ii) Spleen cells were fused with the myeloma cell 
line P3-x 63-Ag8-653 according to Di Pauli 1141 
modified by Galen et al. [lo]. 
(iii) Antibodies to the peptides were detected in 
mouse serum, culture medium, ascites and purified 
IgG fractions by RIA. The binding to iodinated 
peptides was determined after separation of bound 
and free peptide using polyethylene glycol [ 151. 
(iv) Antibody producing hybridomas were 
cloned by limiting dilution. 
2.6, Mass production and purification 
Ascites were produced by intraperitoneal injec- 
tion of cloned hybridoma cells into pristane treated 
Balb/C mice. Monoclonal antibodies were purified 
by affinity chromatography on protein A- 
Sepharose [16]. 
2.7. EIMA of inactive renin 
The different monoclonal antibodies were tested 
by EIMA for inactive renin in chorionic cells [9] 
and plasma (fig.2). This assay measures inactive 
renin in a ‘sandwich’ between two mono~lon~ an- 
tibodies. The F(ab)‘2 fragments of the first 
monoclonal antibody (3E8) [lo] (anti total renin 
monoclonal antibody) were coated on polyvinyl 
microtitration plates (0.1 mg/ml) in 10 mM 
phosphate buffer (pH 7.4) for 18 h at 4°C. 
Medium from cultured chorionic cells or plasma 
was then added in 10 mM phosphate buffer con- 
taining 1% bovine gamma globulin (BGG) and 
0.1 OTo Tween 20, and incubated for 2 h at 4°C. The 
different anti-peptide monoclonal antibodies were 
then added and incubated for 18 h at 4°C. The 
wells were washed in phosphate buffered saline 
(PBS)-Tween 20 and inactive renin identification 
by the second monoclonal antibody was deter- 
mined by adding mouse IgG anti Fc peroxidase an- 
tibodies (Jackson Immunoresearch Laboratories). 
Controls were performed by replacing the 
monoclon~ antipeptide antibodies by the 
monoclonal active renin antibody 4G1, and in- 
cubating, as above with inactive renin activated by 
acidification to pH 3.3 for 18 h at 4°C. 
2.8. Analytical affinity c~rom~togra~~y 
Two monoclonal antibodies were purified for 
this experiment: the (- 19 to - 7) antibody and the 
(- 26 to - 17) antibody. The antibodies were 
coupled to cyanogen bromide activated Sepharose 
4B [17] using 5 mg IgG/ml moist gel. 90% of the 
IgG were effectively coupled to the gel. Each 
coupled antibody was then incubated with the 
pooled human renin-rich plasma in a ratio of 3 : 1 
(3 ml plasma/ml gel) for 18 h at 4°C with shaking. 
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and RIMA ([lo] and Simon et al., in preparation) 
before and after activation by different concentra- 
tions of trypsin (O-l mg/ml). 
3. RESULTS 
3.1. Production of monoclonal antibodies 
After fusion, 11 hybridomas directed against he 
two synthetic renin prosegment peptides were ob- 
tained. 10 of them produced monoclonal an- 
tibodies directed against he (- 26 to - 17) peptide 
whereas a single hybridoma produced an antibody 
against he ( - 19 to - 7) peptide. These results are 
in accordance with the humoral immunity of the 
mouse. Indeed on the fusion day, the titer of the 
immune serum was l/200 for ( - 19 to - 7) and 
l/3200 for (- 26 to - 17). This difference in im- 
munity response was probably due to an antigenic 
competition phenomenon. The two monoclonal 
antibodies used for affinity chromatography had 
association constants (&) measured by Scatchard 
analysis [15] of 3.9 x 10’ and 4 x lo9 M-’ for the 
( - 19 to - 7) and ( - 26 to - 17) antibody, respec- 
tively. Isotypes were determined by immunoelec- 
trophoresis with anti subclass mouse antibodies. 
The two antibodies were IgGs, the (- 19 to - 7) 
antibody was an IgG2a and the (- 26 to - 17) an- 
tibody was an IgGl. 
3.2. Immunoenzymometric assay 
The ability of the 11 monoclonal antibodies to 
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recognize inactive renin was tested on a pool of 
human plasma and on the medium of cultured 
chorionic cells (fig.2). None of the 10 antibodies 
directed against the peptide ( - 26 to - 17) 
recognized inactive renin, since an enzymatic 
signal equal to the background was observed. We 
reversibly activated the inactive renin by lowering 
the pH in order to try to alter the conformation of 
0 
Fig.2. Immunoenzymometric assay. This assay measures 
inactive renin in a sandwich between two monoclonal 
antibodies. (A) The F(ab)‘Z fragment of an anti total 
renin monoclonal antibody (3E8) were coated on 
microtitration plates. (B) The ( - 19 to - 7) monoclonal 
antibody was then incubated. (C) The identification of 
inactive renin was determined by mouse IgG anti Fc 
peroxidase antibodies. 
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Fig.3. Analytical affinity chromatography. The 
monoclonal antibodies: (0) the (- 19 to - 7) antibody 
and (a) the (- 26 to - 17) antibody were coupled to 
cyanogen bromide activated Sepharose 4%. A poo1 of 
human renin rich plasma was then added for 18 h at 
4°C. The filtrate from each column was analyzed by (A) 
IRMA and (B) PRA before and after activation by 
different concentrations of trypsin. 
the prosegment and to expose the sequence (- 26 
to - 17) at the surface of the molecule. No binding 
was observed. Only the (- 19 to - 7) monoclonal 
antibody directed against the C-terminal part of 
the prosegment specifically recognized the inactive 
renin. This inactive renin was not recognized by 
this antibody after trypsin activation, but was 
recognized after activation by acidification. 
3.3. Analytical affinity chromatography 
The results of analytical affinity 
chromatography of human plasma on (- 19 to 
- 7) antibody-gel and ( - 26 to - 17) antibody-gel 
are shown in fig.3A and B. The filtrate of the 
4C7-gel contained inactive renin which was detec- 
table after activation by trypsin: the value for ac- 
tive renin by RIMA was 340 pg/ml before 
activation and 5 14 pglml after activation of inac- 
tive renin. In contrast, 340 pg/ml of inactive renin 
were detected in the filtrate of the (- 19 to - 7) 
antibody-gel, both before and after activation by 
trypsin. Thus the inactive renin was bound to the 
column. These results were confirmed by assay of 
PRA in the two filtrates (fig.3B). 
4. DISCUSSION 
Region specific monoclonal antibodies raised 
against synthetic peptides having the sequence of 
the prosegment of human renin can be useful tools 
for establishing the structure of inactive renin. In 
the present study, 11 such antibodies were 
prepared and used to analyze the structure of 
plasma inactive renin before and after activation. 
A single antibody recognized the ( - 19 to - 7) pep- 
tide, the remaining 10 reacted with the (-26 to 
- 17) peptide. The (- 19 to - 7) peptide cor- 
responds to the C-terminal region of the proseg- 
ment while the (- 26 to - 17) peptide corresponds 
to the middle region (see fig.1). 
The ability of these monoclonal antibodies to 
recognize inactive renin was evaluated by RIMA 
and analytical immunoaffinity chromatography. 
Only the anti (- 19 to - 7) peptide antibody 
reacted with inactive renin. Hirose et al. [6] ob- 
tained similar results using polyclonal antibodies 
to prosegment peptides. They found that a single 
antibody (antipro 3), directed against the (- 15 to 
- 1) peptide, identified inactive renin. This strong- 
ly suggests that the prosegment of human renin 
contains at least the ( - 19 to - 1) sequence. 
These data may be used as the basis of at least 
two hypotheses for the activation of the renin 
precursor. The first possibility, as suggested by 
Hirose et al. 161, is that plasma inactive renin lacks 
a large portion of the NH2-terminal part of the 
profragment and may represent a proteolyzed ac- 
tivation intermediate. The second hypothesis is 
that the antibodies directed against the center part 
of profragment ( - 26 to - 17) cannot recognize in- 
active renin because this part of the molecule is 
buried on the inside of renin or because it 
represents a discontinuous epitope. 
These two hypotheses can be discussed in the 
light of the pepsinogen-pepsin model. There is a 
high degree of homology between the pro- 
fragments of renin and pepsin, at the 
NH2-terminal region where most of the basic 
amino acids are conserved in similar position. The 
three dimensional structure of prorenin is not 
known and no molecular modeling has yet been 
reported. However, the three dimensional struc- 
ture of pepsinogen has been recently described by 
James and Sielecki [ 191. The 44 residues of pep- 
sinogen are numbered between Leu-44 and Leu-1 . 
After a large N-terminal extension formed by the 
first 8 residues, Leu-44-Arg-36, three short helical 
stretches are seen: Ser-33-Asp-25, Lys-23-Thr-16 
(these sequences are in an approximately or- 
thogonal position to each other and contain 
hydrophobic residues) and Pro-l I-Tyr-7. The 
chain from His-15 to Asn-12 has an extended con- 
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formation. From Pro-6 in the profragment to 
Asn-8 in pepsin, the polypeptide chain forms a 
large loop into the center of which fits the tip of 
the flap. The peptide bond between Leu-1 and Ile-1 
is exposed at the surface of the molecule. The con- 
formation of pepsinogen is stabilized at neutral pH 
by electrostatic binding forces. At acidic pH, a 
conformational change occurs due to the disrup- 
tion of the electrostatic forces by protonation of 
the carboxylate groups. In the case of pepsinogen, 
an intramolecular activation occurs leading to an 
activation intermediate. 
By analogy, it is tempting to speculate a similar 
conformation for prorenin. Indeed, renin is rever- 
sibly activated by exposure to acidic pH and it is 
likely that acidification provokes a disruption of 
electrostatic forces between basic amino acids of 
the profragment and renin itself. The irreversible 
activation of renin might occur after proteolytic 
cleavage after one of the two dibasic pairs 
(Lys-3%Arg-34, Lys-30-Arg-29). 
The inability of (- 26 to - 17) monoclonal an- 
tibody to recognize plasma inactive renin activated 
by acidification is consistent with (i) plasma inac- 
tive renin having lost residues - 43 to - 20 of the 
renin profragment or (ii) a spatial structure of the 
synthetic peptide in inactive renin completely dif- 
ferent from its original structure in solution (where 
both peptides were recognized by monoclonal an- 
tibodies). Clearly this point merits further in- 
vestigations. X-ray crystallographic studies and the 
isolation and sequencing of the plasma renin pro- 
segment would help to establish the validity of one 
of these hypotheses. It would then be possible to 
decide whether inactive renin is a proteolyzed ac- 
tivation intermediate or whether its spatial confor- 
mation masks its N-terminal extremity which 
would result in the absence of recognition by 
specific N-terminal antibodies. 
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